Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
1.460
+0.040 (2.82%)
Jan 2, 2026, 11:49 AM EST - Market open

Edesa Biotech Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212017 - 2020
Period Ending
Jan '26 Sep '25 Sep '24 Sep '23 Sep '22 Sep '21 2017 - 2020
121714131498
Upgrade
Market Cap Growth
81.24%20.29%8.40%-6.42%-85.44%26.16%
Upgrade
Enterprise Value
114127190
Upgrade
Last Close Price
1.422.474.454.426.4551.66
Upgrade
Forward PE
----56.67-
Upgrade
PB Ratio
3.181.407.291.891.527.49
Upgrade
P/TBV Ratio
9.7514.32-2.742.009.16
Upgrade
Debt / Equity Ratio
--0.010.010.000.01
Upgrade
Quick Ratio
10.6010.600.713.293.907.64
Upgrade
Current Ratio
10.6810.680.913.534.258.29
Upgrade
Return on Equity (ROE)
-99.57%-99.57%-136.66%-101.88%-156.34%-120.39%
Upgrade
Return on Assets (ROA)
-57.02%-57.02%-69.02%-56.33%-87.78%-116.79%
Upgrade
Return on Capital (ROIC)
-68.42%-68.42%-95.89%-69.64%-101.75%-131.97%
Upgrade
Return on Capital Employed (ROCE)
-63.50%-63.50%-354.10%-130.50%-194.70%-180.40%
Upgrade
Earnings Yield
-60.72%-41.34%-42.70%-62.82%-123.19%-13.64%
Upgrade
FCF Yield
-61.87%-42.12%-33.84%-49.78%-86.24%-13.98%
Upgrade
Buyback Yield / Dilution
-77.54%-77.54%-11.84%-36.37%-21.50%-40.32%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q